7Baggers
 Published on: 2025-10-03 00:24:41  newser.com Fri, 03 Oct 2025 05:24:41 GMT
 Published on: 2025-09-29 10:18:49  newser.com Mon, 29 Sep 2025 15:18:49 GMT
 best momentum stocks to buy for october 14th  MSN Tue, 23 Sep 2025 13:05:35 GMT
 published on: 2025-09-20 07:06:07  khodrobank.com Sat, 20 Sep 2025 03:39:17 GMT
 published on: 2025-09-20 07:06:07  khodrobank.com Fri, 19 Sep 2025 21:38:26 GMT
 published on: 2025-09-15 04:53:58  newser.com Mon, 15 Sep 2025 09:53:58 GMT
 diamedica therapeutics (nasdaq:dmac) upgraded at wall street zen  MarketBeat Sun, 14 Sep 2025 09:23:16 GMT
 diamedica therapeutics (nasdaq:dmac) upgraded at wall street zen  MarketBeat Sat, 13 Sep 2025 17:39:17 GMT
 stocks in play: empire company limited  Barchart.com Thu, 11 Sep 2025 13:34:00 GMT
 mda space recognized as a tsx30 company  Barchart.com Tue, 09 Sep 2025 12:05:00 GMT
 published on: 2025-09-09 04:27:14  Newser Tue, 09 Sep 2025 09:27:14 GMT
 After Golden Cross, DiaMedica Therapeutics, Inc. (DMAC)'s Technical Outlook is Bright  Zacks Investment Research Tue, 09 Sep 2025 07:00:00 GMT
 diamedica therapeutics to participate in upcoming investor conferences  MarketScreener Mon, 08 Sep 2025 14:33:16 GMT
 published on: 2025-09-07 21:48:55  뉴스영 Mon, 08 Sep 2025 09:22:01 GMT
 published on: 2025-09-05 23:26:43  خودرو بانک Fri, 05 Sep 2025 19:57:13 GMT
 DiaMedica Therapeutics to Participate in Upcoming Investor Conferences  Business Wire Fri, 05 Sep 2025 07:00:00 GMT
 iota finishing a bullish triangle?  Barchart.com Thu, 04 Sep 2025 09:05:30 GMT
 Trill AB buys DiaMedica (DMAC) shares worth $5.96 million  Investing.com Thu, 04 Sep 2025 07:00:00 GMT
 published on: 2025-09-03 04:58:56  Newser Wed, 03 Sep 2025 09:58:56 GMT
 published on: 2025-09-03 08:43:38  خودرو بانک Wed, 03 Sep 2025 05:14:10 GMT
 published on: 2025-08-31 02:38:18  Newser Sun, 31 Aug 2025 07:38:18 GMT

DiaMedica Therapeutics Inc
(NASDAQ:DMAC) 

DMAC stock logo

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. Its lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which has completed Phase Ib clinical trials for the treatment of patients with modera...

Founded: 2000
Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends